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Abstract 
Aims  To determine the effectiveness of self-audit tools designed to detect miscoding, 
misclassification and misdiagnosis of diabetes in primary care.  
Methods  We developed six searches to identify people with diabetes with potential classification 
errors.  The search results were automatically ranked from most to least likely to have an underlying 
problem.  Eight practices with a combined population of 72 000 and diabetes prevalence 2.9% 
(n = 2340) completed audit forms to verify whether additional information within the patients’ 
medical record confirmed or refuted the problems identified.  
Results  The searches identified 347 records, mean 42 per practice. Pre-audit 20% (n = 69) had Type 1 
diabetes, 70% (n = 241) had Type 2 diabetes, 9% (n = 30) had vague codes that were hard to classify, 
2% (n = 6) were not coded and one person was labelled as having gestational diabetes.  Of records, 
39.2% (n = 136) had important errors: 10% (n = 35) had coding errors; 12.1% (42) were misclassified; 
and 17.0% (59) misdiagnosed as having diabetes.  Thirty-two per cent (n = 22) of people with Type 2 
diabetes (n = 69) were misclassified as having Type 1 diabetes; 20% (n = 48) of people with Type 2 
diabetes (n = 241) did not have diabetes; of the 30 patients with vague diagnostic terms, 50% had 
Type 2 diabetes, 20% had Type 1 diabetes and 20% did not have diabetes. Examples of misdiagnosis 
were found in all practices, misclassification in seven and miscoding in six. 
Conclusions  Volunteer practices successfully used these self-audit tools.  Approximately 40% of 
patients identified by computer searches (5.8% of people with diabetes) had errors; misdiagnosis is 
commonest, misclassification may affect treatment options and miscoding in omission from disease 
registers and the potential for reduced quality of care.  
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Introduction 
There is an international epidemic in diabetes [1] with increased prevalence reported globally [2–4].  
However, the reporting of change in prevalence may be undermined if there are errors in routine 
data which are not addressed.  Misclassification matters because it affects treatment choices and risk 
management.  Furthermore, misdiagnosis can have psychological and financial implications, and the 
combination of miscoding, misclassification and misdiagnosis may undermine measures of the quality 
of care and research based on routine data [5].   
 
There are known problems with the diagnosis, classification and coding of diabetes [6–8], which have 
been confirmed in studies using databases drawn from routinely collected data [9].  These databases 
were from two independent research projects: (1) Cutting out Needless Deaths Using Information 
Technology (CONDUIT; n = 221 958), a study which explored ethnic disparities in diabetes [10,11] and 
the longitudinal change in cardiovascular risk management [12]; and (2) Quality Improvement in 
Chronic Kidney Disease (QICKD; n = 942 031), a newer, much larger study based on a national sample 
[13,14], which, although primarily a study of quality improvement in chronic kidney disease, includes 
the investigation of diabetes and other vascular risk factors.  These studies concluded that between 
10 and 25% of patients with Type 2 diabetes were incorrectly classified as Type 1 diabetes and 5% of 
those with Type 2 diabetes had no objective evidence of diabetes [9].  
 
For reasons of ethical and practical data management most research databases do not incorporate 
the whole computerized medical record (CMR).  The computerized medical record contains two 
principal components: (1) coded data—e.g. diagnosis of diabetes, coded as ‘C10‘ using the Read 
classification method in the UK [15]; and (2) free text or narrative record—i.e. the text that the doctor 
enters into the record and documents, such as hospital and clinic letters.  Coded data are relatively 
easy to process and less likely to compromise a patient’s privacy than free text.  
 
We carried out this study to test the effectiveness of a downloadable toolkit designed to enable 
practitioners to identify people with diabetes who are miscoded, misclassified or misdiagnosed. 
 
Methods 
The Classification of Diabetes (CoD) programme specified the development of audit tools that could 
be used by general practitioners, to identify patients with incorrectly classified diabetes.  
Classification of Diabetes is an initiative of the National Health Service (NHS) Diabetes and the Royal 
College of General Practitioners (RCGP) in England and information can be accessed online [16].  The 
Classification of Diabetes programme includes the development of audit tools that practitioners or 
localities can use to identify patients with classification problems.  We followed the model we have 
previously used to identify patients suitable for referral to a new psychological therapy service, which 
consisted of data extraction queries and a step-by-step user guide for most of the brands of primary 
  
care computerized medical record systems [17].  A flow chart provides an overview of the process 
(Fig. 1).  
 
We incorporated the naming conventions used in the Classification of Diabetes in this paper. These 
include definitions of miscoding, misclassification and misdiagnosis, as well as a practical algorithm for 
classifying diabetes. (1) Miscoding occurs when the wrong code is applied, generally the use of a non-
specific code. For example, when use of a non-specific diabetes code is used, it does not allow the 
type of diabetes to be precisely determined. (2) Misclassification is defined as when a case is 
incorrectly classified into a category to which the subject does not belong. (3) Misdiagnosis is the 
allocation of an incorrect diagnosis; diagnosing diabetes in someone who does not have the 
condition.  The algorithm provides practical guidance on how to classify diabetes according to World 
Health Organization (WHO) categories.  However, it adds an ’Unclassified‘ group for patients who are 
early in the diagnostic process or in whom there is genuine uncertainty; and groups with impaired 
glucose tolerance or with gestational diabetes into ’Non-diabetic hyperglycaemia’.  It also uses the 
classification ’other‘ to include the secondary causes of diabetes.   
 
We carried out this audit in eight practices, five in Surrey and three in south-west London.  The 
practices had a combined list size of 72 000 [18] and a mean of 9000 patients (median 10 043) per 
practice.  However, the Surrey practices were larger (mean 12 931) compared with the London 
practices (mean 2448).  The practices had all created a disease register of people with diabetes, as 
part of pay-for-performance (P4P) quality targets [19].  These disease registers contained a total of 
2340 people with diabetes, representing an overall prevalence of 3.2% (range 2.9–3.9%).  The 
auditors were trained by one of the authors (SdeL), including jointly running through cases until the 
auditor was happy to continue the process; SdeL met and reviewed with the auditor any problematic 
cases and discussed these with a co-author (KK).  The audits were carried out in two practices by 
general practitioners who ran their practice diabetes clinic, in one by a specialist diabetes nurse, and 
in two by practice nurses who were trained and ran their practice-based clinics.  In three practices, 
the audits were initiated by general practitioner diabetes leads, but the audit was carried out by a 
final year medical student (NS). 
 
We developed six simple Morbidity Information Query and Export Syntax (MIQUEST) computer 
searches to explore whether it was feasible for these to be run in practice.  MIQUEST is a Department 
of Health-sponsored data extraction tool, capable of extracting data from different brands of general 
practitioner computer system.  We ran these queries in ’local‘ mode within individual practices, so 
that it produced simple data tables of patients requiring notes reviewed for the practice to process. 
The MIQUEST query processor and general practitioner computerized record systems cannot carry 
out the sophisticated data processing carried out in the original study [5], so we developed searches, 
  
technically called queries, using simple logic to identify the groups of patients we were interested in 
(Fig. 2).  We accepted that there may be some overlap between the queries. 
 
The six queries extracted diagnostic data (disease code and date) and drug therapy codes (relevant 
drug code and date) to look for inconsistencies between diagnosis and therapy or biochemistry.  The 
first three queries identify people with misclassification of Type 1 diabetes. They look for people with 
the Type 1 diabetes disease code not prescribed insulin; where insulin and an oral anti-diabetes drug 
(OAD) are prescribed; and where oral anti-diabetes drugs are started before insulin and insulin is not 
started within 6 months of diagnosis.  The fourth query explores misclassification of Type 2 diabetes 
by extracting the Type 2 diabetes disease code and then looking for prescription codes for insulin 
within 6 months of diagnosis.  The fifth query looks to identify misdiagnosis of Type 2 diabetes by 
extracting the disease code for Type 2 diabetes, oral anti-diabetes drug and Insulin data, plasma 
glucose and HbA1c data.  These data are sorted in two ways: firstly, to identify people with a disease 
code compatible with Type 2 diabetes, who are not taking an oral anti-diabetes drug or insulin, and 
who have not ever had an HbA1c ≥ 48 mmol/mol (6.5%) or plasma glucose ≥ 7.0 mmol/l; secondly, the 
query identifies the people taking an oral anti-diabetes drug who lack a diagnosis of diabetes.  The 
final query flags people with vague diabetes codes.  The precise code ranges used are listed within the 
queries, which can be downloaded from our website (http://www.clininf.eu/cod). 
 
When we tested the MIQUEST searches, we found that the interface between MIQUEST and the 
computer system is implemented in subtly different but important ways in the various brands of 
computerized medical record systems.  For example, the MIQUEST manual [20] says that you can 
request maximum values, for example, highest plasma glucose.  However, this feature is not 
implemented in one of the general practitioner computerized medical record systems we worked 
with.  We therefore had to produce queries that listed all patients with a condition, treatment or 
pathology result and then reorder them within a spread sheet (Microsoft Excel) to identify the high-
risk patients. 
 
The next steps of the process involved developing a user-friendly method of data sorting and an audit 
form to collect data about the cases identified.  We developed a Microsoft Excel macro which allowed 
the output files generated by the queries to be placed in a single folder and be sorted from most likely 
to least likely to have coding or classification problems.  We did not precisely specify the number of 
cases each practice should review.  We created an illustrated step-by-step user guide and an audit 
form and placed these online [21]. The audit tool was developed as part of the Classification of 
Diabetes programme and was initially piloted in two practices. An audit form was completed for each 
case reviewed.  The audit was designed to collect the minimum amount of data required to clarify an 
individual patient’s diagnosis.  The audit collected the most recent data available for a patient as well 
as any data collected at the point of diagnosis or at the earliest record of having diabetes.  
  
 
Statistical tests 
We used Pearson χ2-test to compare whether there were any statistical differences in proportion 
between groups.  We used an independent samples t-test to see if there are any differences in age, 
plasma glucose, HbA1c or BMI between those found to be misdiagnosed and those with diabetes and 
a paired sample t-test to compare any change in continuous variables between diagnosis and latest 
measurement.  We conducted our analysis using SPSS (PASW statistics) version 18 (SPSS Inc., Chicago, 
IL, USA). 
 
Ethical considerations 
The findings of the study of coded data from the CONDUIT study and QICKD trial data led NHS 
Diabetes to roll out a national programme to improve the quality of the classification of diabetes [22] 
in line with WHO recommendations [23].  Identifiable data were only held at practice level, with 
anonymized data held at St George’s and only capable of being re-identified within contributing 
practices.  This audit was a test of implementing these national recommendations by volunteer 
practices with direct responsibility of the care of their patients, and consistent with the General 
Medical Council guidance to participate in local audit [24] and National Research Ethics Service 
definitions [25] of clinical audit.  
 
Results 
 
Cases audited 
Audit forms were completed for 347 patients representing 14.8% (347/2340) of the people labelled as 
having diabetes in the practice computerized medical record system.  There were 162 women with a 
median age of 65.5 years (range 15–97 years; interquartile range 49–76 years).  The corresponding 
data for men (n = 185) were: median age 63 years (range 16–95 years, interquartile range 54–
71 years).  The audit form took between 10 and 40 min to complete.  A small number of cases were 
complex and required extensive review of the whole record and discussion with authors SdeL and KK. 
 
All types of diabetes were identified by the audit, including cases not included in the pay-for-
performance disease register.  Most of the cases identified were Type 2 diabetes (69.5%, n = 241) and 
Type 1 diabetes (19.9%, n = 69).  Eleven per cent (n = 37) of patients identified by the searches would 
not have been included in the pay-for-performance disease registers.  This was either because they 
use vague codes not readily mapped to a type of diabetes or because they were identified from being 
prescribed treatment for diabetes (Table 1). 
 
  
Miscoding, misclassification and misdiagnosis of diabetes 
As a result of the case review, at least 16% (n = 59) of the patients diagnosed with diabetes were 
found to be incorrectly diagnosed and did not have the condition.  These 59 comprised 57 without 
diabetes (13 of whom had impaired glucose tolerance) and two with gestational diabetes (Table 2).  
There were two cases within the audit where the patients concerned had no objective record of 
diabetes within their record other than a single blood glucose reading; these were 16.4 mmol/l and 
20.9 mmol/l.  These results superficially meet the diagnostic criteria for diabetes [22]. 
 
We identified misclassification with people with Type 2 diabetes being classified as having Type 1 
diabetes; misdiagnosis of Type 2 diabetes when patients actually did not have diabetes; and patients 
who had vague diabetes codes or prescribed medications for diabetes, most of whom had Type 2 
diabetes.  Thirty-two per cent of patients (22 out of 69) flagged with Type 1 diabetes actually had 
Type 2 diabetes (Table 3).  Eleven patients coded as having Type 2 diabetes had Type 1 diabetes and 
48 patients coded with Type 2 diabetes did not have diabetes at all.  Of the patients with a vague 
diagnosis code for their diabetes (none of whom could not be readily classified as Type 1 diabetes or 
Type 2 diabetes), four did not have diabetes, six had Type 1 diabetes and 15 had Type 2 diabetes.  
Five cases of secondary diabetes were identified in patients with a pre-audit diagnosis of Type 2 
diabetes.  In the four cases where a pre-audit diagnosis of Type 1 diabetes turned out not to be 
diabetes: two cases were patients who had pancreatic transplants, although these may be patients 
who continue to be reviewed; one a very obese person who had been on insulin at one stage but 
there was no evidence of diabetes (there were no elevated plasma glucose or glycated haemoglobin 
results in his records, although a strong family history was noted and we cannot rule out that this 
person did not have Type 2 diabetes now controlled by diet.)  The final case appeared to be a coding 
error. 
 
Overall impact of the audit 
Overall, the effect of the audit was to change the diagnosis of approximately 40% (n = 136) of the 
patients identified by the tool.  This comprised 5.8% (136/2340) of the patients on the diabetes 
registers across these practices.  There was no change in 60.8% of the patients (n = 211); 17% (59) had 
a misdiagnosis, based on non-diabetic levels of plasma glucose and HbA1c, and no need for ongoing 
therapy; 12.2% (42) were misclassified and 10.1% (35) had been miscoded.   
 
Which searches were most useful 
All six of the searches in the audit identified people who required change (Table 4).  The searches 
which identified the largest proportion of people requiring change in coding were those labelled as 
having Type 2 diabetes. People with Type 1 diabetes requiring a change in coding were more often 
identified through the process of completing the audit form.   
 
  
Pointers towards patients more likely to require change 
We explored whether problems in coding, classification or diagnosis in patients' records were 
different in terms of age, BMI or glycaemic control.  The mean ages of patients who were miscoded, 
misclassified or misdiagnosed and those who were not were similar (61.8 vs. 61.3 years). People with 
miscoding, misclassification and misdiagnosis had similar BMI (28.5 vs. 28.1 kg/m2) at the time of 
diagnosis.  However, whilst there was no difference in HbA1c at the time of diagnosis 
[HbA1c = 62 mmol/mol (7.8%) vs. 61 mmol/mol (7.7%) for no change vs. change groups], in the latest 
results HbA1c was significantly lower in the group whose coding was changed [HbA1c = 56 mmol/mol 
(7.3%), SD = 2.14 vs. HbA1c = 50 mmol/mol (6.7%), SD = 2.14; t-test, P = 0.019]. 
 
Comparing patients misdiagnosed with a combined misclassified and miscoded group 
We also compared those misdiagnosed (i.e. patients we thought did not have diabetes) with the 
misclassified and miscoded as a single group and discovered that the misdiagnosed group have a 
lower HbA1c and plasma glucose, although there was no difference in their age or BMI at diagnosis or 
at their latest reading.  The patients who were misclassified or miscoded had a mean HbA1c of 
78 mmol/mol (9.3%) (SD 8.5), whereas those misdiagnosed had an HbA1c of 40 mmol/mol (5.8%) 
(SD 1.7) at diagnosis.  The most recent HbA1c values were also significantly different [62 mmol/mol 
(7.8%) or vs. 34 mmol/mol (5.3%), respectively].  Plasma glucose at diagnosis was 12.8 mmol/l (SD 6.0) 
vs. 8.5 mmol/l (SD 3.2).  These differences are all highly statistically significant (t-test, P = 0.003 for 
earliest HbA1c and P < 0.001 for plasma glucose and latest HbA1c).  
Over the time between first recording and the most recent reading, the misdiagnosed groups 
maintained much lower HbA1c readings [earliest HbA1c 40 mmol/mol (5.8%) (SD 1.7), latest 
34 mmol/mol (5.3%) (SD 1.0), P = 0.001].  
 
Variation in cases found by practice 
Cases were identified in all practices; the median number of cases audited per practice was 44 
(interquartile range 36.5–55.3) and the median number where a change was needed was 17.0 
(interquartile range 10.8–18.8).  All practices had at least one misdiagnosed case, all but one 
identified a case of misclassification and all but two found examples of miscoding (Table 4). 
 
Discussion 
 
Principal findings 
This audit shows that there is scope to improve diabetes data quality and that computer searches 
may have a role in achieving such a rise in data quality.  The audit also demonstrates how self-
directed audits can be downloaded and successfully conducted in practice and validates the findings 
of previous studies using research databases.  Approximately 40% of the cases identified through the 
  
audit had a coding change as a result, with misdiagnosis being the largest group.  Two patients who 
had ’diabetic‘ blood test results subsequently have no features of diabetes. 
 
Implications of the findings 
Some practices are able to run this self-directed audit toolkit, and this approach to clinical audit has a 
place among the armamentarium of quality improvement tools.  There is scope to improve the quality 
of care of people currently labelled as having diabetes; some may not have diabetes; others are 
misclassified and may not be managed according to correct guidance; and people who are miscoded 
will not be included in the pay-for-performance register so will not be automatically flagged or 
recalled by most general practitioner computerized medical record systems.  Where they are not 
automatically recalled (. such as secondary causes of diabetes), practice recall systems need to be put 
in place to ensure they receive quality care.  Where patients appear to be very well controlled and 
have consistently low HbA1c, practices should consider the possibility that the patient does not have 
diabetes.  There should be a high level of suspicion where a patient was diagnosed on a single blood 
test.  
 
Comparison with the literature 
This audit was conducted because a previous systematic review identified few studies of classification 
problems in diabetes [9].  The prevalence of diabetes based on the participating practices’ pay-for-
performance disease registers is 3.2% and within 0.1% of a national survey of pay-for-performance 
prevalence [26].  The pay-for-performance register is likely to underestimate prevalence because 
some patients with diabetes were coded using vague codes that are not included in the disease 
register.  This partially explains why studies of routine data that are inclusive of all relevant codes 
report a higher prevalence, approximately 4.0% [27–29].  
 
Computer prompts could potentially improve quality and coding of diabetes.  Randomized controlled 
trials in family practice have found reminders to test for diabetes have improved detection [30] and 
prompts to improve primary prevention are effective [31].  Patients who are included in the pay-for-
performance disease register will be subject to reminders and prompts, albeit in varying formats on 
the different brands of computerized medical record system [32], whereas those with diabetes not 
included in this register will not be.  It is plausible that exclusion from the pay-for-performance 
disease register contributes to lower standards of glycaemic control. 
 
HbA1c has been proposed as a better diagnostic tool than fasting glucose or oral glucose tolerance 
tests [33].  Where a diagnosis of diabetes has been made on the basis of a single plasma glucose test, 
and HbA1c is below the levels proposed for the diagnosis of diabetes, we suggest that practitioners 
consider challenging the diagnosis. 
 
  
Limitations of the study 
The limitations of working with routine data, which is inevitably incomplete, are well known [34].  The 
clinicians conducting the audit often opportunistically noted problems with the coding and 
classification of diabetes, which were not necessarily those intended to be highlighted by the search.  
We did not manually search all the records so are unable to comment on the sensitivity of this 
method.  Whilst we found a MIQUEST-naive medical student could complete the searches, it is 
possible that some practices may lack someone with the skills to run these searches.  These practices 
may be able to get support from a local data quality or audit facilitator.  
 
Call for further research 
Further study would enable us to develop and improve these audit tools further and explore false 
positives and cases missed.  Process evaluation would provide insight into the usability of this toolkit 
[35]. 
 
Conclusions 
Problems with the coding classification and diagnosis of diabetes seen in a study of coded data from 
research databases are present in routine data and practices should consider running the audit 
(available at http://www.clininf.eu/cod).  However, over half the patients identified required no 
change and individual patient problems were often complex and sometimes not the ones the search 
was intended to find.  Every person with diabetes who attends for review should be critically 
reviewed to check whether they are correctly classified and coded.  
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Figure 1  Audit overview flow chart. MIQUEST, Morbidity Information Query and Export Syntax. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Go to the Clinical Informatics website: 
http://clininf.eu/cod/  
Select the brand of computerized medial 
record (CMR) system used in your 
practice (UK CMR systems only) 
2. The Extraction Guide provides a step-
by-step guide to the data extraction 
The Search Set contains the MIQUEST 
queries to run extract the audit results 
3. The audit results are placed into a 
folder with the Microsoft Excel macro 
labelled Diabetes spreadsheet 
The macro highlights, in yellow, patients 
who need further review 
5. An Audit Form, also downloadable 
from http://clininf.eu/cod/ is provided to 
assist in systematic audit data collection 
6. Change coding, classification or 
diagnosis of diabetes for the appropriate 
patients 
In pilot practices approximately 40% of 
cases identified required change 
4. Review the records of the patients 
highlighted in each search to confirm or 
refute the possible coding/classification 
/diagnosis problems 
  
 
Figure 2  Six queries to identify patients with miscoded, misclassified and misdiagnosed diabetes. 
  
 
 
 
 
Three queries to look at misclassification of Type 1 diabetes  
1. Patients with a diagnosis of type 1 diabetes not prescribed insulin 
2. Patients with a diagnosis of type 1 diabetes on insulin currently taking an oral anti-diabetic medicine  
other than metformin.  Patients with type 1 diabetes should not routinely be concurrently 
prescribed an oral anti-diabetic medicine,  an exception being metformin for weight loss 
3. Patients with a diagnosis of type 1 diabetes who started their oral anti-diabetic medicine before 
insulin will have started insulin within 6 months of diagnosis . 
One query to look at misclassification of Type 2 diabetes  
4. Patients who have required insulin from within 6 months of diagnosis.  Patients prescribed insulin 
but who do not have a diagnosis of diabetes are also detected by this query 
One query to look at misdiagnosis of Type 2 diabetes 
5. Patients with type 2 diabetes not prescribed insulin or an oral anti-diabetic medicine (excluding 
metformin) or had no abnormal tests—plasma glucose and HbA1c—are unlikely to have diabetes.  
Patients prescribed an oral anti-diabetic medicine (excluding metformin) but who do not have a 
diagnosis of diabetes are also detected by this query 
Miscoding in diabetes 
6. Some patients with diabetes are miscoded.  Their disease is only coded with vague codes (e.g. C100z 
’Diabetes without mention of complications‘), which inform the patient has diabetes but cannot be 
classified 
  
Table 1  Cases identified by running the searches listed in Fig. 2 
 
  Audit cases 
  n % 
Type 1 diabetes 69 19.9 
Type 2 diabetes 241 69.5 
Vague/unclassified 30 8.6 
Not coded 6 1.7 
Gestational 1 0.3 
Total 347 100 
 
 
 
Pre-audit classification Post-audit classification 
Non diabetic 
hyperglycaemia 
  
Pre-
audit 
Total 
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 1
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ss
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ed
 Patients with 
diabetes 
Subtotal 
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al 
Impaired 
glucose 
tolerance 
N
ot
 d
ia
be
te
s Patients 
without 
diabetes 
Subtotal 
  n n % n % n % n % n % n % n % n % n % 
Type 1 diabetes 69 35 50.7 22 31.9 2 2.9 5 7.2 64 92.8 0 0.0 0 0.0 5 7.2 5 7.2 
Type 2 diabetes 241 11 4.6 174 72.2 5 2.1 3 1.2 193 81.0 0 0.0 13 5.4 35 14.5 48 19.0 
Vague/unclassified 30 6 20.0 15 50.0 0 0.0 3 10.0 24 83.3 2 6.7 0 0.0 4 13.3 6 16.7 
Not coded 6 1 16.7 3 50.0 0 0.0 2 33.3 6 100 0 0.0 0 0.0 0 0.0 0 0.0 
Gestational 1 0 0.0 1 100 0 0.0 0 0.0 1 100 0 0.0 0 0.0 0 0.0 0 0.0 
Total 347 53 15.3 215 62.0 7 2.0 13 3.7 291 83.9 2 0.6 13 3.7 41 11.8 59 16.1 
 
Table 2  Cross-tabulation of pre- and post-audit types of diabetes 
 
 
  
Table 3  The cases and problems identified by each of the six searches 
 
Query No change Miscoding Misclassification Misdiagnosis Total 
No. 
Problem type the query 
intended to identify 
n % n % n % n % n % 
1 
Misclassification type 
1diabetes 15 7.1 1 2.9 8 19.0 3 5.1 27 7.8 
2 
Misclassification type 
1diabetes 24 11.4 12 34.3 17 40.5 1 1.7 54 15.6 
3 
Misclassification type 1 
diabetes 4 1.9 1 2.9 2 4.8 0 0.0 7 2.0 
4 
Misclassification type 2 
diabetes 56 26.5 7 20.0 11 26.2 5 8.5 79 22.8 
5 Misdiagnosis type 2 diabetes 43 20.4 0 0.0 2 4.8 40 67.8 85 24.5 
6 Miscoding in diabetes 69 32.7 14 40.0 2 4.8 10 16.9 95 27.4 
Total   211 100 35 100 42 100 59 100 347 100 
 
 
 
 
  
 
Table 4  Changes as a result of the audit by practice  
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    N n % n % n % n % n % n % 
1 Surrey 11 000 53 0.5 438 3.9 17 3.9 10 2.3 5 1.1 2 0.5 
2 Surrey 12 000 41 0.3 373 3.2 10 2.7 0 0.0 8 2.1 2 0.5 
3 Surrey 9000 47 0.5 254 2.9 21 8.3 6 2.4 0 0.0 15 5.9 
4 Surrey 15 000 64 0.4 477 3.2 33 6.9 3 0.6 11 2.3 19 4.0 
5 Surrey 18 000 26 0.1 525 2.9 18 3.4 0 0.0 9 1.7 9 1.7 
6 London 2500 40 1.7 91 3.9 11 12.1 3 3.3 3 3.3 5 5.5 
7 London 2500 14 0.5 101 3.9 9 8.9 3 3.0 5 5.0 1 1.0 
8 London 2500 62 2.6 81 3.3 17 21.0 10 12.3 1 1.2 6 7.4 
  TOTAL 72 000 347 0.5 2340 3.2 136 5.8 35 1.5 42 1.8 59 2.5 
 
 
 
 
